Some very good news for people with asthma and COPD.
The first new treatment for acute attacks in over 50 years—
a monoclonal antibody vs interleukin-5 receptor-α—with efficacy in a randomized trial
www.thelancet.com/journals/lan...

I feel like half of programming is remembering how weird stuff works and the other half is setting things up so that you do not have to remember the weird stuff

An interesting editor for navigating and refactoring code: haystackeditor.com

Trying this starter pack thing - go.bsky.app/BnFjosi

I wish all of the people spreading doom and gloom about AI's energy consumption put it into perspective. The amount of energy you save by not using GPT/DALLE/etc for a year is utterly dwarfed by the energy you save skipping meat for a week.

(Though AI producers should still pursue efficiency!)

I can't speak for Xerox PARC, but Bell Labs prospered in its heyday in large part because of its unique model: The legislated research arm of a regulated monopoly. As the pieces of that model fell away, especially starting in 1984's consent decree, commercialism started warping the mindset.

Hello, BlueSky! 🦋